Compositions and methods that enhance an immune response
AssigneeChrontech Pharma AB
InventorsMatti Sällberg, Lars Frelin
Life of this patent
Estimating the term…
Loading patent…
AssigneeChrontech Pharma AB
InventorsMatti Sällberg, Lars Frelin
Estimating the term…
Disclosed herein are isolated nucleic acids, compositions of isolated nucleic acids, and compositions of polypeptides that are useful for the generation, enhancement, or improvement of an immune response to a target antigen. Some embodiments of the compositions include hepatitis B core antigen (HBcAg) protein and a heterologous protein antigen. In some embodiments, an isolated nucleic acid encoding hepatitis B core antigen (HBcAg) protein and a heterologous protein antigen is disclosed. Also disclosed herein are methods of administering the composition or isolated nucleic acid to generate an immune response, where HBcAg acts as adjuvant to improve the immune response to the heterologous protein. In certain embodiments, the HBcAg is as a stork or heron hepatitis antigen.
An isolated nucleic acid comprising:
An immunogenic composition comprising:
Dependencies are inferred from the claim text.